EUR/CAD (EURCAD=X)

CCY - CCY Delayed price. Currency in CAD

Add to watchlist

1.3906

+0.0028

(+0.2010%)

At close: 10:29PM GMT

Business Wire
Vertex Reports First Quarter 2022 Financial Results
BOSTON, May 05, 2022--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2022 and reiterated full year 2022 product revenue guidance.
Simply Wall St.
Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 137%
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Stockopedia
Why the strengths of Vertex Pharmaceuticals Inc could see it ride out economic uncertainty
The best calibre of companies resist competitive threats year-in, year-out, while their competitors fail. This cycle of consistent outperformance and reinvestm...